Advances in sentinel node dissection in prostate cancer from a technical perspective

International Journal of Urology

Volumn 22, Issue 10, 2015, Pages 898-909

  Acar, Cenk ^a   Kleinjan, Gijs H ^b,c   van den Berg, Nynke S ^b,c   Wit, Esther Mk ^c   van Leeuwen, Fijs Wb ^b,c   van der Poel, Henk G ^c  

^a ACIBADEM UNIVERSITY   (Turkey)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Biopsy; Indocyanine green; Nuclear imaging; Prostate cancer; Sentinel lymph node

Indexed keywords

INDOCYANINE GREEN; NANOCOLLOID TC 99M; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; COLORING AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ARTERY INJURY; BONE INFECTION; CANCER RADIOTHERAPY; CANCER STAGING; DEEP VEIN THROMBOSIS; FEVER; FLUORESCENCE IMAGING; GAMMA CAMERA; GAMMA RADIATION; HUMAN; LAPAROSCOPE; LUNG EMBOLISM; LYMPHANGIOGRAPHY; LYMPHOCELE; LYMPHOSCINTIGRAPHY; MALE; OPTICS; PELVIS LYMPH NODE; PERIPHERAL EDEMA; PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; ADVERSE EFFECTS; DISSECTION; FLUORESCENCE; LABORATORY DIAGNOSIS; LYMPH NODE; LYMPH NODE METASTASIS; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; SCINTISCANNING; SURGERY;

COLORING AGENTS; DISSECTION; FALSE NEGATIVE REACTIONS; FLUORESCENCE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84943615222     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12863     Document Type: Review

References (65)

1. Briganti A, Blute ML, Eastham JH et al. Pelvic lymph node dissection in prostate cancer. Eur. Urol. 2009; 55: 1251-65.
2. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J. Urol. 1996; 156: 1969-71.
3. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J. Urol. 2002; 167: 1681-6.
4. Joniau S, Van den Bergh L, Lerut E et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur. Urol. 2013; 63: 450-8.
5. Rousseau C, Rousseau T, Campion L et al. Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: a prospective study of 200 patients. J. Nucl. Med. 2014; 55: 753-8.
6. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-66.
7. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R. The sentinel lymph node concept in prostate cancer - first results of gamma probe-guided sentinel lymph node identification. Eur. Urol. 1999; 36: 595-600.
8. van der Poel HG, Buckle T, Brouwer OR, Valdes Olmos RA, van Leeuwen FW. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur. Urol. 2011; 60: 826-33.
9. Manny TB, Patel M, Hemal AK. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur. Urol. 2014; 65: 1162-8.
10. Kizu H, Takayama T, Fukuda M et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J. Nucl. Med. Technol. 2005; 33: 78-82.
11. Van Den Berg NS, Buckle T, Kleinjan GI et al. Hybrid tracers for sentinel node biopsy. Q. J. Nucl. Med. Mol. Imaging 2014; 58: 193-206.
12. Vermeeren L, Muller SH, Meinhardt W, Valdes Olmos RA. Optimizing the colloid particle concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 2010; 37: 1328-34.
13. Buckle T, Brouwer OR, Valdes Olmos RA, van der Poel HG, van Leeuwen FW. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J. Nucl. Med. 2012;53:1026-33.
14. Harisinghani MG, Barentsz J, Hahn PF et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 2003; 348: 2491-9.
15. Turkbey B, Hoyt RF Jr, Agarwal HK et al. Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model. Acad Radiol 2015; 22: 646-52.
16. Winter A, Woenkhaus J, Wawroschek F. A novel method for intraoperative sentinel lymph node detection in prostate cancer patients using superparamagnetic iron oxide nanoparticles and a handheld magnetometer: the initial clinical experience. Ann. Surg. Oncol. 2014; 21: 4390-6.
17. Horenblas S. Lymphadenectomy in penile cancer. Urol. Clin. North Am. 2011; 38: 459-69, vi-vii.
18. Egawa M, Fukuda M, Takashima H, Misaki T, Kinuya K, Terahata S. The sentinel node concept in prostate cancer: present reality and future prospects. Indian J. Urol. 2008; 24: 451-6.
19. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn. J. Clin. Oncol. 1999; 29: 604-7.
20. van Leeuwen FW, Hruby S. Fluorescence guidance during radical prostatectomy. Eur. Urol. 2014; 65: 1169-70.
21. Jeschke S, Lusuardi L, Myatt A, Hruby S, Pirich C, Janetschek G. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging. Urology 2012; 80: 1080-6.
22. Wawroschek F, Wengenmair H, Senekowitsch-Schmidtke R et al. Prostate lymphoscintigraphy for sentinel lymph node identification in canines: reproducibility, uptake, and biokinetics depending on different injection strategies. Urol. Res. 2003; 31: 152-8.
23. Brenot-Rossi I, Bastide C, Garcia S et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur. J. Nucl. Med. Mol. Imaging 2005; 32: 635-40.
24. Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C. Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur. J. Nucl. Med. Mol. Imaging 2008; 35: 32-8.
25. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2, 000 patients. Eur. J. Nucl. Med. Mol. Imaging 2009; 36: 1377-82.
26. Silva N Jr, Anselmi CE, Anselmi OE et al. Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl. Med. Commun. 2005; 26: 1081-6.
27. Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J. Urol. 2004; 171: 2268-71.
28. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J. Urol. 2001; 166: 1715-9.
29. Wawroschek F, Vogt H, Wengenmair H et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol. Int. 2003; 70: 303-10.
30. Weckermann D, Holl G, Dorn R, Wagner T, Harzmann R. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int. 2007; 99: 1036-40.
31. Winter A, Kneib T, Henke RP, Wawroschek F. Sentinel lymph node dissection in more than 1200 prostate cancer cases: rate and prediction of lymph node involvement depending on preoperative tumor characteristics. Int. J. Urol. 2014; 21: 58-63.
32. Vermeeren L, Valdes Olmos RA, Meinhardt W et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J. Nucl. Med. 2009; 50: 865-70.
33. Fukuda M, Egawa M, Imao T, Takashima H, Yokoyama K, Namiki M. Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J. Urol. 2007; 177: 1313-7; discussion 7.
34. Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99 m nanocolloid into the prostate with and without preoperative imaging. Eur. Urol. 2007; 52: 126-32.
35. Povoski SP, Neff RL, Mojzisik CM et al. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J. Surg. Oncol. 2009; 7: 11.
36. Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J. Urol. 2005; 173: 1943-6.
37. Meinhardt W, van der Poel HG, Valdes Olmos RA, Bex A, Brouwer OR, Horenblas S. Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area. Prostate Cancer 2012; 2012: 751753.
38. Vermeeren L, Valdes Olmos RA, Meinhardt W et al. Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur. J. Nucl. Med. Mol. Imaging 2009; 36: 1029-36.
39. Vermeeren L, Valdes Olmos RA, Meinhardt W, Horenblas S. Intraoperative imaging for sentinel node identification in prostate carcinoma: its use in combination with other techniques. J. Nucl. Med. 2011; 52: 741-4.
40. van den Berg NS, Valdes-Olmos RA, van der Poel HG, van Leeuwen FW. Sentinel lymph node biopsy for prostate cancer: a hybrid approach. J. Nucl. Med. 2013; 54: 493-6.
41. Brouwer OR, Buckle T, Bunschoten A et al. Image navigation as a means to expand the boundaries of fluorescence-guided surgery. Phys. Med. Biol. 2012; 57: 3123-36.
42. KleinJan GH, van den Berg NS, Brouwer OR et al. Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer. Eur. Urol. 2014; 66: 991-8.
43. Inoue S, Shiina H, Arichi N et al. Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine green. Can. Urol. Assoc. J. 2011; 5: 254-9.
44. Corvin S, Schilling D, Eichhorn K et al. Laparoscopic sentinel lymph node dissection-a novel technique for the staging of prostate cancer. Eur. Urol. 2006; 49: 280-5.
45. Hacker A, Jeschke S, Leeb K et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J. Urol. 2006; 176: 2014-8; discussion 8-9.
46. Meinhardt W, Valdes Olmos RA, van der Poel HG, Bex A, Horenblas S. Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int. 2008; 102: 714-7.
47. Rousseau C, Rousseau T, Bridji B et al. Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma. Eur. J. Nucl. Med. Mol. Imaging 2012; 39: 291-9.
48. Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R. Sentinel lymph node dissection for prostate cancer: experience with more than 1, 000 patients. J. Urol. 2007; 177: 916-20.
49. de B-DA, Roberto BO, Meinhardt W, Valdes-Olmos RA. Lymphatic drainage in prostate carcinoma assessed by lymphoscintigraphy and SPECT/CT: its importance for the sentinel node procedure. Rev. Esp. Med. Nucl. Imagen Mol. 2012; 31: 66-70.
50. Jeschke S, Beri A, Grull M et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur. Urol. 2008; 53: 126-32.
51. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 1993; 2: 335-9; discussion 40.
52. Ponholzer A, Lamche M, Klitsch M et al. Sentinel lymphadenectomy compared to extended lymphadenectomy in men with prostate cancer undergoing prostatectomy. Anticancer Res. 2012; 32: 1033-6.
53. Stanik M, Capak I, Macik D et al. Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer. Int. Urol. Nephrol. 2014; 46: 1543-9.
54. van der Poel HG, de Blok W, Tillier C, van Muilekom E. Robot-assisted laparoscopic prostatectomy: nodal dissection results during the first 440 cases by two surgeons. J. Endourol. 2012; 26: 1618-24.
55. Krengli M, Ballare A, Cannillo B et al. Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66: 1100-4.
56. Vermeeren L, Meinhardt W, van der Poel HG, Valdes Olmos RA. Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer. Eur. J. Nucl. Med. Mol. Imaging 2010; 37: 2021-6.
57. Neto AS, Tobias-Machado M, Ficarra V et al. Dynamic sentinel node biopsy for inguinal lymph node staging in patients with penile cancer: a systematic review and cumulative analysis of the literature. Ann. Surg. Oncol. 2011; 18: 2026-34.
58. Luo S, Lobo AZ, Tanabe KK et al. Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes. JAMA Surg. 2015; 150: 465-72.
59. Patten DK, Zacharioudakis KE, Chauhan H, Cleator SJ, Hadjiminas DJ. Sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with breast cancer: are the current false negative rates acceptable? Breast 2015; 24: 318-20.
60. Boileau JF, Poirier B, Basik M et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J. Clin. Oncol. 2015; 33: 258-64.
61. Brouwer OR, van den Berg NS, Matheron HM et al. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye. Eur. Urol. 2014; 65: 600-9.
62. Kadkhodayan S, Hasanzadeh M, Treglia G et al. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur. J. Surg. Oncol. 2015; 41: 1-20.
63. Janetschek G, Hruby S. Editorial comment on "Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer". Scand. J. Urol. 2015; 49: 77-8.
64. Briganti A, Chun FK, Salonia A et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur. Urol. 2006; 50: 1006-13.
65. Schilling D, Boekeler U, Gakis G et al. Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer. World J. Urol. 2010; 28: 715-20.